Oral 17-alpha alkylated anabolic steroids bypass first-pass hepatic metabolism via chemical modification, making them hepatotoxic. Monitoring AST, ALT, and GGT is essential during any oral AAS cycle.
17-alpha alkylation (17-AA) resisting hepatic breakdown, concentrating the compound in liver cells
Cholestatic liver injury reducing bile flow — hallmark of oral AAS hepatotoxicity
Concurrent alcohol use dramatically amplifying hepatotoxic risk
Pre-existing liver conditions (NAFLD, viral hepatitis) lowering the threshold for drug-induced liver injury
GearCheck correlates your symptoms with your actual lab values and flags the specific markers driving the issue — not just a generic panel review.
Analyze My Bloodwork →GearCheck provides blood marker analysis and harm reduction education. Information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional.